Sign in
4

Changes in Ownership

CAPRICOR THERAPEUTICS, INC. Filed Acc 0001593087-26-000007

CHIEF FINANCIAL OFFICER sold 25,000 shares at $31.70 ($792,540)

  • CHIEF FINANCIAL OFFICER acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergmann Anthony CHIEF FINANCIAL OFFICER 2026-05-01 Option exercise 10b5-1 +25,000 $3.18 $79,500 33,223 D
Bergmann Anthony CHIEF FINANCIAL OFFICER 2026-05-01 Sale 10b5-1 −25,000 $31.70 $792,540 8,223 D
Derivatives
Bergmann Anthony CHIEF FINANCIAL OFFICER 2026-05-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 116,980 D
Open-market sales · 25,000 sh · avg $31.70 · $792,540
Loading xslF345X06/form4-05042026_040501.xml…